This Week in Aesthetics: April 12-16

This week in aesthetics, we highlight baricitinib for hair regrowth in alopecia areata patients, the April “Meet the Aesthetic Expert” column, and more.

This week in aesthetics, a study highlights baricitinib for hair regrowth in alopecia areata patients, Will Kirby, DO, FAOCD, interviews Amy Spizuoco, DO, FAOCD, FAAD, in the April “Meet the Aesthetic Expert” column, a study examines the role of vitamin D in keloid scar treatment, and Michael Kluska, DO, discusses Evolve by InMode in his monthly device review.

Baricitinib Shows Hair Regrowth in Phase 3 Study for AA

Eli Lilly and Incyte announce results from its phase 3 study evaluating baricitinib 2 mg and 4 mg for the treatment of alopecia areata, making it the first phase 3 study with top-line results in patients with the hair disorder.

The Role of Vitamin D in Keloid Scar Treatment

A recent study in the Journal of Cosmetic Dermatology examines the safety and efficacy of using vitamin D intralesional injection for the treatment of keloid scars.

Meet the Aesthetic Expert With Dr Will Kirby: Amy Spizuoco, DO, FAOCD, FAAD

In this month’s "Meet the Aesthetic Expert" column, Will Kirby, DO, FAOCD, talks with dual board-certified dermatologist and dermatopathologist Amy Spizuoco, DO, FAOCD, FAAD, about her new role as president-elect of AOCD, the coveted millennial patient population, and how to leverage health and beauty for a more holistic approach to aesthetics.

Device Review: Evolve

In this monthly technology review, Michael Kluska, DO, discusses Evolve by InMode, including device overview, cost, ROI, patient perceptions, and candidate considerations.